Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits

Circulation

Volumn 99, Issue 23, 1999, Pages 2979-2982

  Qian, HuSheng ^a   Neplioueva, Valentina ^a   Shetty, Geetha A ^a   Channon, Keith M ^a   George, Samuel E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Cell adhesion molecules; Endothelium; Gene therapy; Nitric oxide; Viruses

Indexed keywords

BETA GALACTOSIDASE; CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; LEUKOSIALIN; NITRIC OXIDE SYNTHASE; VASCULAR CELL ADHESION MOLECULE 1;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE MARKER; DOSE TIME EFFECT RELATION; GENE THERAPY; GENE TRANSFER; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; INFLAMMATORY INFILTRATE; LIPID STORAGE; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; TREATMENT OUTCOME;

EID: 0033564035     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.23.2979     Document Type: Article

References (19)

1. Cooke JP. Role of nitric oxide in progression and regression of atherosclerosis. West J Med. 1996;164:419-424.
2. Simon DI, Stamler JS, Jaraki O, Keaney JF, Osborne JA, Francis SA, Singel DJ, Loscalzo J. Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor. Arterioscler Thromb. 1993;13:791-799.
3. De Caterina R, Libby P, Peng H-B, Thanniekal VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, Liao JK. Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 1995;96:60-68.
4. Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein I in cultured human endothelial cells. Circ Res. 1995;76:980-986.
5. Wang BY, Candipan RC, Arjomandi M, Hsiun PT, Tsao PS, Cooke JP. Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits. J Am Coll Cardiol. 1996;28:1573-1579.
6. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83: 1774-1777.
7. Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res. 1996;78:225-230.
8. Channon KM, Blazing MA, Shetty GA, Potts KE, George SE. Adenoviral gene transfer of nitric oxide synthase: high level expression in human vascular cells. Cardiovasc Res. 1996;32:962-972.
9. Channon KM, Qian HS, Blazing MA, Olmez E, Pawloski J, Shetty GA, Youngblood SA, McMahon T. Stamler JS, George SE. In vivo gene transfer of nitric oxide synthase enhances vasomotor function in carotid arteries from normal and cholesterol-fed rabbits. Circulation. 1998;98: 1905-1911.
10. Channon KM, Qian HS, Youngblood SA, Olmez E, Shetty GA, Blazing MA, George SE. Acute host-mediated endothelial injury after adenoviral gene transfer in normal rabbit arteries: impact on transgene expression and endothelial function. Circ Res. 1998;82:1253-1262.
11. Nunnari JJ, Zand T, Joris I, Majno G. Quantitation of oil red 0 staining of the aorta in hypercholesterolemic rats. Exp Mol Pathol. 1989;51:1-8.
12. Li H, Cybulsky MI, Gimbrone MA, Libby P. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb. 1993;13:197-204.
13. Yla-Herttuala S, Lipton BA, Rosenfeld ME, Sarkioja T, Yoshimura T, Leonard EJ, Witztum JL, Steinberg D. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A. 1991;88:5252-5256.
14. Gauthier TW, Scalia R, Murohara T, Guo JP, Lefer AM. Nitric oxide protects against leukocyte-endothelium interactions in the early stages of hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1995;15; 1652-1659.
15. Bath PM. The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular CGMP concentrations in vitro. Eur J Clin Pharmacol. 1993;45:53-58.
16. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992;90:1168-1172.
17. Cayatte AJ, Palacino JJ, Horten K, Cohen RA. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb. 1994;14: 753-759.
18. Tsao PS, Wang B, Buitrago R, Shyy JY, Cooke JP. Nitric oxide regulates monocyte chemotactic protein-1. Circulation. 1997;96:934-940.
19. Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 1998;394:894-897.